companydata.dkRenescience A/S: Financial statements 2012
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -20,994,000 and a net result of DKK -16,641,000. Equity amounted to DKK 17,605,000. The solvency ratio was 74%.
- Gross Profit
- -20,994,000 kr.
- Profit/Loss
- -16,641,000 kr.
- Equity
- 17,605,000 kr.
- Total Assets
- 23,778,000 kr.
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of August 27, 2012, Henrik Maimann is registered as director of Renescience A/S.
As of August 27, 2012, Nanna Dreyer Nørholm has stepped down as director of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.